SCOUT Trial Reports on the Safety Profile of Sibutramine in Patients with Cardiovascular Diseases

Aldo Maggioni

doi:10.3810/psm.2009.10.1734

Related publications

Article2009

Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead‐in Period

Ian D. Caterson, Walmir Coutinho, Nick Finer, Luc Van Gaal, Aldo Maggioni, Christian Torp‐Pedersen, Arya M. Sharma, Hong Ge, D Santoro, Gillian Shepherd, Philip James

Article2007

Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial

Christian Torp‐Pedersen, Ian D. Caterson, Walmir Coutinho, Nick Finer, Luc Van Gaal, Aldo Maggioni, Arya M. Sharma, Wygenia Brisco, Roger Deaton, Gillian Shepherd, Philip James

Article2013

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Aldo Maggioni, Sally Greene, Gregg C. Fonarow, Michael Böhm, Faı̈ez Zannad, Scott D. Solomon, E. F. Lewis, Fabio Baschiera, Tien Hua, Claudio Gimpelewicz, Anastasia Lesogor, Mihai Gheorghiade, S. Ramos, Antoni Bayés de Luna, Santiago Miriuka, Maria Canto Diez, Enrico Perna, Hugo A Luquez, J. G. Pinna, Jorge Castagnino, Pedro Alvarenga, Joaquı́n Ibáñez,

Article2020

Blood pressure management in hypertensive patients with syncope: how to balance hypotensive and cardiovascular risk

Giulia Rivasi, Michele Brignole, Martina Rafanelli, Grzegorz Bilo, Martino F. Pengo, Andrea Ungar, Gianfranco Parati

Article2023

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

Junji Furuse, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, Katsuaki Motoyoshi, Masatoshi Kudo